AN2 Therapeutics (ANTX) Return on Assets [ROA] (2022 - 2026)
AN2 Therapeutics (ANTX) reported Return on Assets [ROA] of -42.89% for Q2 2026, up 4.68 percentage points from -47.57% a year earlier and up 3.36 percentage points from the prior quarter.
Powered by 
Analysis
AN2 Therapeutics (ANTX) Return on Assets [ROA] (2022 - 2026) Analysis & Trends
For FY2025, AN2 Therapeutics posted Return on Assets [ROA] of -45.67%, down 1.20 percentage points from FY2024.
- Return on Assets [ROA] has a three-year change of +3.07 percentage points (FY2022 to FY2025).
- By year, Return on Assets [ROA] came in at -44.47% in FY2024 (+9.22 pp), -53.69% in FY2023 (-4.95 pp) and -48.74% in FY2022.
- The Q2 2026 figure ranks as the highest quarterly Return on Assets [ROA] since Q4 2022.
- Year over year, Return on Assets [ROA] gained in five of the last eight quarters, with an average year-over-year change of +2.42 percentage points.
- The high point for year-over-year Return on Assets [ROA] in five years was Q3 2025 (a gain of 13.23 percentage points); the low point was Q2 2023 (a drop of 31.92 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at -46.24% (Q1 2026), -54.46% (Q4 2025) and -47.51% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 19.00% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 8.08% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 7.32% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 1.87% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 9.36% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 9.80% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -7.67% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 2.00% |
| 10 | AN2 Therapeutics | 164.30 Mn | -121.79 Mn | - | -42.96% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -42.96% |
| Jun 30, 2026 | -42.94% |
| Mar 31, 2026 | -46.31% |
| Dec 31, 2025 | -54.41% |
| Sep 30, 2025 | -47.58% |
| Jun 30, 2025 | -47.50% |
| Mar 31, 2025 | -52.31% |
| Dec 31, 2024 | -54.34% |
| Sep 30, 2024 | -58.65% |
| Jun 30, 2024 | -56.21% |
| Mar 31, 2024 | -50.61% |
| Dec 31, 2023 | -43.81% |
| Sep 30, 2023 | -46.89% |
| Jun 30, 2023 | -56.91% |
| Mar 31, 2023 | -50.24% |
| Dec 31, 2022 | -38.86% |
| Sep 30, 2022 | -32.34% |
| Jun 30, 2022 | -27.13% |
| Mar 31, 2022 | -29.39% |
API Access
AN2 Therapeutics Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=ANTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "ANTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=ANTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();